Long-term outcomes of amniotic membrane transplantation for repair of leaking glaucoma filtering blebs.

PURPOSE: To report long-term results of human preserved amniotic membrane transplant (AMT) vs conjunctival advancement for repair of late-onset glaucoma filtering bleb leakage. DESIGN: Randomized, controlled trial (n = 30). METHODS: Rates of bleb failure (reoperation for glaucoma or recurrent bleb leak) were compared. RESULTS: Median follow-up was 80 months. Final intraocular pressure (IOP) was 10.9 +/- 0.9 mm Hg with AMT and 12.7 +/- 1.3 mm Hg with conjunctival advancement (P = .28). The number of glaucoma medications and final visual acuities were similar between groups. Bleb vascularity was significantly less with AMT (P = .02). Seven failures occurred with AMT, four requiring reoperation for bleb leakage and three requiring reoperation for glaucoma. Four failures occurred with conjunctival advancement, one requiring reoperation for leakage and three requiring reoperation for glaucoma. Kaplan-Meier survival curves were statistically similar between groups, with a trend favoring conjunctival advancement (P = .44). CONCLUSIONS: Although prone to early releakage, AMT may be a suitable alternative to conjunctival advancement in the long-term.

Aging, progenitor cell exhaustion, and atherosclerosis.

BACKGROUND: Atherosclerosis is largely attributed to chronic vascular injury, as occurs with excess cholesterol; however, the effect of concomitant vascular aging remains unexplained. We hypothesize that the effect of time in atherosclerosis progression is related to obsolescence of endogenous progenitor cells that normally repair and rejuvenate the arteries. METHODS AND RESULTS: Here we show that chronic treatment with bone marrow-derived progenitor cells from young nonatherosclerotic ApoE-/- mice prevents atherosclerosis progression in ApoE-/- recipients despite persistent hypercholesterolemia. In contrast, treatment with bone marrow cells from older ApoE-/- mice with atherosclerosis is much less effective. Cells with vascular progenitor potential are decreased in the bone marrow of aging ApoE-/- mice, but cells injected from donor mice engraft on recipient arteries in areas at risk for atherosclerotic injury. CONCLUSIONS: Our data indicate that progressive progenitor cell deficits may contribute to the development of atherosclerosis.

Myopia affects retinal nerve fiber layer measurements as determined by optical coherence tomography.

PURPOSE: To determine whether increasing myopia is associated with thinner peripapillary retinal nerve fiber layer (RNFL) when measured by Stratus optical coherence tomography (OCT). DESIGN: Observational cross-sectional study. METHODS: Normal subjects with myopia underwent refractometry, axial length measurement (IOL Master), optic nerve examination, and OCT (12 fast RNFL scans/eye). The more myopic eye was chosen as the study eye. Correlation coefficients were calculated for demographic and optic disk characteristics, and degree of myopia. RESULTS: Mean age (n=27) was 34+/-8 years (range: 23 to 54). Mean cup-to-disk ratio was 0.38 with 41% large and 59% medium disk size. Eight subjects had peripapillary atrophy and 6 had disk tilt. Mean spherical equivalent was -5.40 D (range: -1.25 to -11.25), with mean axial length of 25.65 mm (range: 22.63 to 27.92). No significant associations were found between RNFL thickness and age (P=0.20), sex, disk size, cup-to-disk ratio, tilt, or peripapillary atrophy. RNFL thickness decreased with higher axial length (overall R=-0.70, P<0.001, superior R=-0.60, P=0.001, and inferior R=-0.60, P=0.001), and higher spherical equivalent (overall R=-0.52, P=0.005, superior R=-0.41, P=0.03, and inferior R=-0.45, P=0.02). Overall RNFL thickness decreased 7 mum/1 mm of axial length, and 3 mum/1 D sphere. CONCLUSIONS: Moderately myopic subjects tend to have thin peripapillary RNFL, mainly at the superior and inferior poles, as measured by Stratus OCT. This phenomenon should be considered when interpreting a glaucoma suspect's Stratus OCT measurements compared with the normative database.

Motility disturbances in the tube versus trabeculectomy study during the first year of follow-up.

PURPOSE: To describe the preoperative and postoperative motility disturbances encountered in the Tube Versus Trabeculectomy (TVT) Study during the first year of follow-up. DESIGN: Multicenter randomized clinical trial. METHODS: settings: Seventeen clinical centers. population: Patients 18 to 85 years old who had previous trabeculectomy and/or cataract surgery and uncontrolled glaucoma with intraocular pressure > or =18 mm Hg and < or =40 mm Hg on maximum tolerated medical therapy. interventions: 350-mm(2) Baerveldt glaucoma implant or trabeculectomy with mitomycin C (MMC). main outcome measures: Preoperative and postoperative evaluation of ocular motility and diplopia. RESULTS: Motility disturbances were detected in 55 patients (28%) at baseline. New-onset persistent diplopia was reported in 5 patients (5%) in the tube group and no patients in the trabeculectomy group at 1 year (P = .06). A new postoperative motility disturbance developed or worsened in 7 patients (9.9%) in the tube group and no patients in the trabeculectomy group during the first year of follow-up (P = .005). Postoperative motility disturbances were also associated with increasing age (P < .001) and right eye surgery (P = .044). CONCLUSIONS: Preoperative motility disturbances were common among patients in the TVT Study. New postoperative motility disturbances were more frequent following tube shunt surgery than trabeculectomy with MMC after 1 year of follow-up.

Atypical angle closures.

PURPOSE OF REVIEW: Primary angle closure typically causes acute intraocular pressure rise in the phakic elderly. Alternative diagnoses, however, for which iridotomy is usually ineffective, occur commonly in younger, nonhyperopic, and pseudophakic patients. RECENT FINDINGS: High-resolution ultrasonography has advanced our understanding of these entities. Management of platueau iris, present in over half of angle closures with patent iridotomy, may depend on disease stage. Early postoperative pseudophakic patients with myopic shift and narrow angle should be treated with laser capsulotomy for capsular block. Bilateral angle closure is usually due to an offending systemic pharmacologic agent, which must be stopped to resolve the closure. Ciliary body swelling often produces angle closure by blocking the access of aqueous to the anterior chamber, sometimes paradoxically after hypotony. Annular choroidal effusions, difficult to detect without ultrasound, may mimic angle closure. Although cycloplegic and corticosteroid therapy may resolve some entities, pars plana vitrectomy and lensectomy may be necessary to resolve severe ciliary block. We also discuss unique variants of angle closure in patients with retinal disease. SUMMARY: Atypical angle closures should always be considered. Careful examination techniques and new technology can detect the mechanisms involved and direct treatment.

Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch.

The small G protein Rac has been implicated in multiple cardiovascular processes. Rac has two major functions: 1) it regulates the organization of the actin cytoskeleton, and 2) it controls the activity of the key enzyme complex NADPH oxidase to control superoxide production in both phagocytes and nonphagocytic cells. In phagocytes, superoxide derived from NADPH has a bactericidal function, whereas Rac-derived superoxide in the cardiovascular system has a diverse array of functions that have recently been a subject of intense interest. Rac is differentially activated by cellular receptors coupled to distinct Rac-activating adapter molecules, with each leading to pathway-specific arrays of downstream effects. Thus it may be important to investigate not just whether Rac is activated but also where, how, and for what effector. An understanding of the biochemical functions of Rac and its effectors lays the groundwork for a dissection of the exact array of effects produced by Rac in common cardiovascular processes, including cardiac and vascular hypertrophy, hypertension, leukocyte migration, platelet biology, and atherosclerosis. In addition, investigation of the spatiotemporal regulation of both Rac activation and consequent superoxide generation may produce new insights into the development of targeted antioxidant therapies for cardiovascular disease and enhance our understanding of important cardiovascular drugs, including angiotensin II antagonists and statins, that may depend on Rac modulation for their effect.